Archives202520242023202220212020201920182017201620152014201320122011 January 10, 2025ImmImmupharma Announces Breakthrough Findings into Autoimmune Diseases Read More January 08, 2025Immupharma at JP MORGAN CONFERENCE and BIOTECH SHOWCASE 11-16 January 2025, San Francisco Read More December 24, 2024Change of Auditor Read More December 04, 2024Appointment of Company Secretary Read More October 11, 2024Notification of Major Holding – Lanstead Capital Read More September 11, 2024Extension of Warrants in Incanthera to 31 March 2025 Read More August 06, 2024TR1 – Major Holding – Lanstead Read More July 01, 20242024 Result of Annual General Meeting – all resolutions passed Read More June 05, 2024Notice of AGM & Annual Report & Accounts Read More June 05, 2024FINAL RESULTS for the twelve months ended 31 December 2023 Read More June 03, 2024Realisation of c£1.5 million on sale of shares in Incanthera plc Read More May 03, 2024TR1 – Major Holding – Lanstead Read More 123…15
January 08, 2025Immupharma at JP MORGAN CONFERENCE and BIOTECH SHOWCASE 11-16 January 2025, San Francisco Read More